SCHEMBL6006454

SCHEMBL6006454

CC(NC=O)NS(=O)(=O)c1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
CYP1A2 P05177 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.51
ADAMTS4 O75173 2/20 0.49
MMP2 P08253 5/20 0.47
MMP13 P45452 4/20 0.47
MMP9 P14780 4/20 0.47
MMP1 P03956 3/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
MMP8 P22894 1/20 0.47
MMP3 P08254 3/20 0.46
MMP7 P09237 2/20 0.46
SLC1A3 P43003 2/20 0.46
SLC1A2 P43004 2/20 0.46
SLC1A1 P43005 2/20 0.46
CA12 O43570 1/20 0.46
CA9 Q16790 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7456509 0.78 ALDH1A1 (0.56) ALDH1A1CYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL945862 0.77 SMN1; SMN2 (0.61) ALDH1A1CYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL6006447 0.75 SMN1; SMN2 (0.51) ALDH1A1CYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL6006659 0.75 SMN1; SMN2 (0.59) ALDH1A1CYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL4714253 0.75 SMN1; SMN2 (0.59) ALDH1A1CYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL11512348 0.75 SMN1; SMN2 (0.59) ALDH1A1CYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL6006460 0.74 SLC1A3 (0.52) ALDH1A1CYP1A2CYP2C9CYP2C19CA1
SCHEMBL790069 0.74 ADAMTS4 (0.81) ALDH1A1CYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL702794 0.74 ADAMTS4 (0.81) ALDH1A1CYP1A2CYP2C9CYP2C19SMN1; SMN2
SCHEMBL702793 0.74 ADAMTS4 (0.81) ALDH1A1CYP1A2CYP2C9CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1207161-B1 NOVEL ISOINDOLE DERIVATIVES BANYU PHARMA CO LTD (JP) 2006-01-18 EP disclosed
US-6777410-B2 SUCH AS 9-(2-METHOXYPHENYL)-3-(1-METHYLETHYL)-(1,3)OXAZOLO-(2,3)ISOINDOLE-2,5(3H,9H)-DIONE; DIABETES AND COMPLICATIONS; OBESITY BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-08-17 US disclosed
EP-1207161-A1 NOVEL ISOINDOLE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2002-05-22 EP disclosed